Silence Therapeutics Plc American Depository Share

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Silence Therapeutics Plc American Depository Share
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Jurisdiction of incorporation: United Kingdom
Headquarters city: London
Headquarters country: United Kingdom
Ticker symbol: SLN
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001479615

Board of directors

Follow this board

Craig A. Tooman · Director · President and CEO
Since 2025
David Lemus · Director
Since 2025
Iain Ross · Director · Interim PEO
Since 2025
James Ede-Golightly · Director
Since 2025
Michael H. Davidson · Director
Since 2025
Rhonda Lynette Hellums · Director · Chief Financial Officer
Since 2026
Timothy Mcinerney · Director
Since 2025

Chief executives

Craig A. Tooman · President and CEO

Since January 2025

0 CEO score

Weak · grade F

Out of 100, from shareholder return, dividends, growth and acquisitions.

Partial: only 20% of the scoring weight is on file.

Revenue growth 20%: 0

20% of the scoring weight is on file. Figures cover December 2024 – December 2025.

Board connections

2 of this board's directors also sit on 4 other boards. 4 are in the same sector.

Shared director Other board Same sector

BioAge Labs Inc. Same sector
via Michael H. Davidson
NewAmsterdam Pharma Company N.V. Same sector
via Michael H. Davidson
Scilex Holding Company Same sector
via David Lemus
Tenax Therapeutics Inc. Same sector
via Michael H. Davidson

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

Akanda Corp. Nasdaq: AKAN · New Romney, United Kingdom Organization Akari Therapeutics plc Nasdaq: AKTX · Tampa, United Kingdom Organization AstraZeneca PLC NYSE: AZN · Cambridge, United Kingdom Organization Autolus Therapeutics plc American Depositary Share Nasdaq: AUTL · London, United Kingdom Organization

Questions about Silence Therapeutics Plc American Depository Share

Who is the CEO of Silence Therapeutics Plc American Depository Share?

Craig A. Tooman has been Silence Therapeutics Plc American Depository Share's President and CEO since January 2025.

How many directors are on Silence Therapeutics Plc American Depository Share's board?

Silence Therapeutics Plc American Depository Share's board has 7 directors: Craig A. Tooman, David Lemus, Iain Ross, James Ede-Golightly, Michael H. Davidson, Rhonda Lynette Hellums and Timothy Mcinerney.

How is Silence Therapeutics Plc American Depository Share connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="silence-therapeutics-plc-american-depository-share"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.